- Home
- ASTS vs RDY Comparison
ASTS vs RDY Comparison
Compare ASTS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTS
- RDY
- Stock Information
- Founded
- ASTS 2019
- RDY 1984
- Country
- ASTS United States
- RDY India
- Employees
- ASTS N/A
- RDY N/A
- Industry
- ASTS Telecommunications Equipment
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- ASTS Consumer Discretionary
- RDY Health Care
- Exchange
- ASTS Nasdaq
- RDY Nasdaq
- Market Cap
- ASTS 13.6B
- RDY 11.6B
- IPO Year
- ASTS N/A
- RDY N/A
- Fundamental
- Price
- ASTS $81.33
- RDY $14.00
- Analyst Decision
- ASTS Hold
- RDY Strong Buy
- Analyst Count
- ASTS 8
- RDY 2
- Target Price
- ASTS $45.82
- RDY $16.95
- AVG Volume (30 Days)
- ASTS 15.3M
- RDY 955.0K
- Earning Date
- ASTS 11-13-2025
- RDY 11-04-2025
- Dividend Yield
- ASTS N/A
- RDY 0.51%
- EPS Growth
- ASTS N/A
- RDY 2.20
- EPS
- ASTS N/A
- RDY 0.79
- Revenue
- ASTS $4,892,000.00
- RDY $3,897,394,052.00
- Revenue This Year
- ASTS $1,257.31
- RDY $7.33
- Revenue Next Year
- ASTS $343.93
- RDY $1.96
- P/E Ratio
- ASTS N/A
- RDY $17.48
- Revenue Growth
- ASTS 249.43
- RDY 15.86
- 52 Week Low
- ASTS $17.50
- RDY $12.26
- 52 Week High
- ASTS $91.41
- RDY $16.17
- Technical
- Relative Strength Index (RSI)
- ASTS 84.76
- RDY 40.98
- Support Level
- ASTS $67.28
- RDY $13.97
- Resistance Level
- ASTS $52.38
- RDY $14.24
- Average True Range (ATR)
- ASTS 5.22
- RDY 0.17
- MACD
- ASTS 3.81
- RDY -0.04
- Stochastic Oscillator
- ASTS 94.23
- RDY 17.78
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.